newsfilter
← Latest News
GlobeNewswire·

LAVA Therapeutics to Participate in the H.C. Wainwright Immune Cell Engager Virtual Conference

UTRECHT, The Netherlands and PHILADELPHIA , Aug. 14, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), an immuno-oncology company focused on developing its proprietary Gammabody® platform of